Smilow Cancer Hospital Care Center at Greenwich
77 Lafayette Place
Greenwich, CT 06830
- Smilow Cancer Hospital Care Center at Greenwich77 Lafayette PlaceGreenwich, CT 06830
Francesca Montanari, MD
Hematologic Oncology, Hematology, Hematology & Oncology
Patient type treated
Adult
Accepting new patients
Yes
Referral required
Not Applicable
Board Certified in
Internal Medicine, Medical Oncology
, and Hematology (Internal Medicine)
Titles
- Assistant Professor of Clinical Medicine (Hematology)
Education & Training
- FellowNew York University (2016)
- ResidentNew York University (2013)
- Post Doctoral Research FellowLaura and Isaac Perlmutter Cancer Center, New York University School of Medicine (2010)
- Post Doctoral Research FellowHerbert Irving Cancer Center, Columbia University (2009)
- FellowUniversity of Pavia Medical Center (2006)
- MDUniversity of Pavia (2002)
Languages Spoken
- English
- Italiano (Italian)
- Español (Spanish)
Additional Information
Board Certifications
- AB of Internal Medicine, Medical Oncology (2016)
- AB of Internal Medicine, Hematology (Internal Medicine) (2016)
Publications
- Sethi T, Montanari F, Foss F. Safety considerations with the current treatments for peripheral T-cell lymphoma. Expert Opinion On Drug Safety 2022, 21: 653-660. PMID: 35129014, DOI: 10.1080/14740338.2022.2036120.
- Leeman-Neill RJ, Soderquist CR, Montanari F, Raciti P, Park D, Radeski D, Mansukhani MM, Murty VV, Hsiao S, Alobeid B, Bhagat G. Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. Haematologica 2022, 107: 201-210. PMID: 33297669, PMCID: PMC8719101, DOI: 10.3324/haematol.2020.267294.
- Sethi TK, Montanari F, Foss F, Reddy N. How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome. British Journal Of Haematology 2021, 195: 352-364. PMID: 33987825, DOI: 10.1111/bjh.17458.
- Scotto L, Kinahan C, Douglass E, Deng C, Safari M, Casadei B, Marchi E, Lue JK, Montanari F, Falchi L, Qiao C, Renu N, Bates SE, Califano A, O'Connor OA. Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways. Molecular Cancer Therapeutics 2021, 20: 1422-1430. PMID: 34108263, PMCID: PMC8941846, DOI: 10.1158/1535-7163.MCT-20-0377.
- Falchi L, Ma H, Klein S, Lue JK, Montanari F, Marchi E, Deng C, Kim HA, Rada A, Jacob AT, Kinahan C, Francescone MM, Soderquist CR, Park DC, Bhagat G, Nandakumar R, Menezes D, Scotto L, Sokol L, Shustov AR, O'Connor OA. Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study. Blood 2021, 137: 2161-2170. PMID: 33171487, DOI: 10.1182/blood.2020009004.
- Montanari F, Orjuela-Grimm M. Joining Efforts for PTLD: Lessons Learned from Comparing the Approach and Treatment Strategies Across the Pediatric and Adult Age Spectra. Current Hematologic Malignancy Reports 2021, 16: 52-60. PMID: 33544319, PMCID: PMC8117403, DOI: 10.1007/s11899-021-00606-8.
- Sawas A, Ma H, Kuruvilla J, Lue JK, Deng C, Marchi E, Montanari F, Cheng B, Savage KJ, Villa D, Crump M, Connors JM, O'Connor OA. Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience. Leukemia & Lymphoma 2020, 61: 3014-3017. PMID: 32720828, DOI: 10.1080/10428194.2020.1795161.
- Scotto L, Kinahan C, Casadei B, Mangone M, Douglass E, Murty VV, Marchi E, Ma H, George C, Montanari F, Califano A, O'Connor OA. Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers. Genes, Chromosomes & Cancer 2020, 59: 639-651. PMID: 32614991, PMCID: PMC7540375, DOI: 10.1002/gcc.22884.
- Ma H, Cheng B, Montanari F, Lue JK, Deng C, Marchi E, O' Connor OA, Sawas A. Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series. Therapeutic Advances In Hematology 2020, 11: 2040620720947340. PMID: 33062232, PMCID: PMC7534065, DOI: 10.1177/2040620720947340.
- O'Connor OA, Falchi L, Lue JK, Marchi E, Kinahan C, Sawas A, Deng C, Montanari F, Amengual JE, Kim HA, Rada AM, Khan K, Jacob AT, Malanga M, Francescone MM, Nandakumar R, Soderquist CR, Park DC, Bhagat G, Cheng B, Risueño A, Menezes D, Shustov AR, Sokol L, Scotto L. Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study. Blood 2019, 134: 1395-1405. PMID: 31471376, DOI: 10.1182/blood.2019001285.
- Radeski D, Montanari F, Alobeid B, O'Connor OA, Bhagat G. Post-transplant lymphoproliferative disorder: a heterogeneous conundrum - response to Weisenburger DD & Gross TG. British Journal Of Haematology 2017, 179: 856-857. PMID: 27471184, DOI: 10.1111/bjh.14272.
- Montanari F, Radeski D, Seshan V, Alobeid B, Bhagat G, O'Connor OA. Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series. British Journal Of Haematology 2015, 171: 491-500. PMID: 26250758, DOI: 10.1111/bjh.13621.
- Montanari F, Diefenbach CS. Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy. Clinical Advances In Hematology & Oncology : H&O 2015, 13: 518-24. PMID: 26351815.
- Montanari F, Diefenbach C. Relapsed Hodgkin lymphoma: management strategies. Current Hematologic Malignancy Reports 2014, 9: 284-93. PMID: 24942298, PMCID: PMC4909353, DOI: 10.1007/s11899-014-0220-7.
- Lipstein M, O'Connor O, Montanari F, Paoluzzi L, Bongero D, Bhagat G. Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma. Clinical Lymphoma, Myeloma & Leukemia 2010, 10: E43-6. PMID: 21856550, DOI: 10.3816/CLML.2010.n.074.
- Montanari F, Bhagat G, Clark-Garvey S, Seshan V, Zain J, Diefenbach C, McCormick E, Crook M, Conroy M, O'Connor OA. Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders. Leukemia & Lymphoma 2010, 51: 1761-4. PMID: 20807097, DOI: 10.3109/10428194.2010.500436.
- Montanari F, O'Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, Crook MT, Tsao L, Sevilla DW, Bhagat G, Alobeid B. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors. Human Pathology 2010, 41: 1150-8. PMID: 20381113, DOI: 10.1016/j.humpath.2009.11.016.
- Arcaini L, Montanari F, Alessandrino EP, Tucci A, Brusamolino E, Gargantini L, Cairoli R, Bernasconi P, Passamonti F, Bonfichi M, Zoli V, Bottelli C, Calatroni S, Troletti D, Merli M, Pascutto C, Majolino I, Rossi G, Morra E, Lazzarino M. Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2008, 19: 1331-1335. PMID: 18344536, DOI: 10.1093/annonc/mdn044.
- Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F, Brusamolino E, Molteni A, Pulsoni A, Cox MC, Orsucci L, Fabbri A, Frezzato M, Voso MT, Zaja F, Montanari F, Merli M, Pascutto C, Morra E, Cortelazzo S, Lazzarino M. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2007, 18: 346-50. PMID: 17071937, DOI: 10.1093/annonc/mdl388.
- Arcaini L, Burcheri S, Rossi A, Pascutto C, Passamonti F, Brusamolino E, Paulli M, Orlandi E, Buelli M, Viero P, Lucioni M, Montanari F, Merli M, Cortelazzo S, Lazzarino M. Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern Italy. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2007, 13: 182-6. PMID: 17200353, DOI: 10.1158/1078-0432.CCR-06-0703.
- Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F, Lucioni M, Motta T, Canzonieri V, Montanari M, Bonoldi E, Gallamini A, Uziel L, Crugnola M, Ramponi A, Montanari F, Pascutto C, Morra E, Lazzarino M. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. British Journal Of Haematology 2007, 136: 301-4. PMID: 17233821, DOI: 10.1111/j.1365-2141.2006.06437.x.
- Arcaini L, Colombo N, Bernasconi P, Calatroni S, Passamonti F, Orlandi E, Bonfichi M, Burcheri S, Porta MD, Rumi E, Montanari F, Algarotti A, Pascutto C, Lazzarino M. Role of the molecular staging and response in the management of follicular lymphoma patients. Leukemia & Lymphoma 2006, 47: 1018-22. PMID: 16840191, DOI: 10.1080/10428190500467834.
- Arcaini L, Colombo N, Passamonti F, Burcheri S, Orlandi E, Brusamolino E, Della Porta M, Rumi E, Montanari F, Pascutto C, Paulli M, Lazzarino M. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment. Leukemia Research 2006, 30: 277-82. PMID: 16112730, DOI: 10.1016/j.leukres.2005.07.006.
- Arcaini L, Burcheri S, Rossi A, Passamonti F, Paulli M, Boveri E, Brusamolino E, Orlandi E, Molteni A, Pulsoni A, Cox MC, Orsucci L, Fabbri A, Frezzato M, Voso MT, Zaja F, Montanari F, Pascutto C, Morra E, Cortelazzo S, Lazzarino M. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. The Oncologist 2006, 11: 285-91. PMID: 16549813, DOI: 10.1634/theoncologist.11-3-285.
- Alessandrino EP, Bernasconi P, Colombo AA, Caldera D, Malcovati L, Troletti D, Vanelli L, Varettoni M, Montanari F, Lazzarino M. Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies. Bone Marrow Transplantation 2004, 34: 1039-45. PMID: 15516936, DOI: 10.1038/sj.bmt.1704717.
- A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.Arcaini L, Orlandi E, Alessandrino EP, Iacona I, Brusamolino E, Bonfichi M, Bernasconi P, Calatroni S, Tenore A, Montanari F, Troletti D, Pascutto C, Regazzi M, Lazzarino M. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma. Bone Marrow Transplantation 2004, 34: 175-9. PMID: 15170171, DOI: 10.1038/sj.bmt.1704551.
Departments and Programs
Locations
Smilow Cancer Hospital Care Center at Greenwich
77 Lafayette Place
Greenwich, CT 06830
- Smilow Cancer Hospital Care Center at Greenwich77 Lafayette PlaceGreenwich, CT 06830
Titles
- Assistant Professor of Clinical Medicine (Hematology)
Education & Training
- FellowNew York University (2016)
- ResidentNew York University (2013)
- Post Doctoral Research FellowLaura and Isaac Perlmutter Cancer Center, New York University School of Medicine (2010)
- Post Doctoral Research FellowHerbert Irving Cancer Center, Columbia University (2009)
- FellowUniversity of Pavia Medical Center (2006)
- MDUniversity of Pavia (2002)
Languages Spoken
- English
- Italiano (Italian)
- Español (Spanish)
Additional Information
Board Certifications
- AB of Internal Medicine, Medical Oncology (2016)
- AB of Internal Medicine, Hematology (Internal Medicine) (2016)
Publications
- Sethi T, Montanari F, Foss F. Safety considerations with the current treatments for peripheral T-cell lymphoma. Expert Opinion On Drug Safety 2022, 21: 653-660. PMID: 35129014, DOI: 10.1080/14740338.2022.2036120.
- Leeman-Neill RJ, Soderquist CR, Montanari F, Raciti P, Park D, Radeski D, Mansukhani MM, Murty VV, Hsiao S, Alobeid B, Bhagat G. Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. Haematologica 2022, 107: 201-210. PMID: 33297669, PMCID: PMC8719101, DOI: 10.3324/haematol.2020.267294.
- Sethi TK, Montanari F, Foss F, Reddy N. How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome. British Journal Of Haematology 2021, 195: 352-364. PMID: 33987825, DOI: 10.1111/bjh.17458.
- Scotto L, Kinahan C, Douglass E, Deng C, Safari M, Casadei B, Marchi E, Lue JK, Montanari F, Falchi L, Qiao C, Renu N, Bates SE, Califano A, O'Connor OA. Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways. Molecular Cancer Therapeutics 2021, 20: 1422-1430. PMID: 34108263, PMCID: PMC8941846, DOI: 10.1158/1535-7163.MCT-20-0377.
- Falchi L, Ma H, Klein S, Lue JK, Montanari F, Marchi E, Deng C, Kim HA, Rada A, Jacob AT, Kinahan C, Francescone MM, Soderquist CR, Park DC, Bhagat G, Nandakumar R, Menezes D, Scotto L, Sokol L, Shustov AR, O'Connor OA. Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study. Blood 2021, 137: 2161-2170. PMID: 33171487, DOI: 10.1182/blood.2020009004.
- Montanari F, Orjuela-Grimm M. Joining Efforts for PTLD: Lessons Learned from Comparing the Approach and Treatment Strategies Across the Pediatric and Adult Age Spectra. Current Hematologic Malignancy Reports 2021, 16: 52-60. PMID: 33544319, PMCID: PMC8117403, DOI: 10.1007/s11899-021-00606-8.
- Sawas A, Ma H, Kuruvilla J, Lue JK, Deng C, Marchi E, Montanari F, Cheng B, Savage KJ, Villa D, Crump M, Connors JM, O'Connor OA. Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience. Leukemia & Lymphoma 2020, 61: 3014-3017. PMID: 32720828, DOI: 10.1080/10428194.2020.1795161.
- Scotto L, Kinahan C, Casadei B, Mangone M, Douglass E, Murty VV, Marchi E, Ma H, George C, Montanari F, Califano A, O'Connor OA. Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers. Genes, Chromosomes & Cancer 2020, 59: 639-651. PMID: 32614991, PMCID: PMC7540375, DOI: 10.1002/gcc.22884.
- Ma H, Cheng B, Montanari F, Lue JK, Deng C, Marchi E, O' Connor OA, Sawas A. Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series. Therapeutic Advances In Hematology 2020, 11: 2040620720947340. PMID: 33062232, PMCID: PMC7534065, DOI: 10.1177/2040620720947340.
- O'Connor OA, Falchi L, Lue JK, Marchi E, Kinahan C, Sawas A, Deng C, Montanari F, Amengual JE, Kim HA, Rada AM, Khan K, Jacob AT, Malanga M, Francescone MM, Nandakumar R, Soderquist CR, Park DC, Bhagat G, Cheng B, Risueño A, Menezes D, Shustov AR, Sokol L, Scotto L. Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study. Blood 2019, 134: 1395-1405. PMID: 31471376, DOI: 10.1182/blood.2019001285.
- Radeski D, Montanari F, Alobeid B, O'Connor OA, Bhagat G. Post-transplant lymphoproliferative disorder: a heterogeneous conundrum - response to Weisenburger DD & Gross TG. British Journal Of Haematology 2017, 179: 856-857. PMID: 27471184, DOI: 10.1111/bjh.14272.
- Montanari F, Radeski D, Seshan V, Alobeid B, Bhagat G, O'Connor OA. Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series. British Journal Of Haematology 2015, 171: 491-500. PMID: 26250758, DOI: 10.1111/bjh.13621.
- Montanari F, Diefenbach CS. Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy. Clinical Advances In Hematology & Oncology : H&O 2015, 13: 518-24. PMID: 26351815.
- Montanari F, Diefenbach C. Relapsed Hodgkin lymphoma: management strategies. Current Hematologic Malignancy Reports 2014, 9: 284-93. PMID: 24942298, PMCID: PMC4909353, DOI: 10.1007/s11899-014-0220-7.
- Lipstein M, O'Connor O, Montanari F, Paoluzzi L, Bongero D, Bhagat G. Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma. Clinical Lymphoma, Myeloma & Leukemia 2010, 10: E43-6. PMID: 21856550, DOI: 10.3816/CLML.2010.n.074.
- Montanari F, Bhagat G, Clark-Garvey S, Seshan V, Zain J, Diefenbach C, McCormick E, Crook M, Conroy M, O'Connor OA. Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders. Leukemia & Lymphoma 2010, 51: 1761-4. PMID: 20807097, DOI: 10.3109/10428194.2010.500436.
- Montanari F, O'Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, Crook MT, Tsao L, Sevilla DW, Bhagat G, Alobeid B. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors. Human Pathology 2010, 41: 1150-8. PMID: 20381113, DOI: 10.1016/j.humpath.2009.11.016.
- Arcaini L, Montanari F, Alessandrino EP, Tucci A, Brusamolino E, Gargantini L, Cairoli R, Bernasconi P, Passamonti F, Bonfichi M, Zoli V, Bottelli C, Calatroni S, Troletti D, Merli M, Pascutto C, Majolino I, Rossi G, Morra E, Lazzarino M. Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2008, 19: 1331-1335. PMID: 18344536, DOI: 10.1093/annonc/mdn044.
- Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F, Brusamolino E, Molteni A, Pulsoni A, Cox MC, Orsucci L, Fabbri A, Frezzato M, Voso MT, Zaja F, Montanari F, Merli M, Pascutto C, Morra E, Cortelazzo S, Lazzarino M. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / ESMO 2007, 18: 346-50. PMID: 17071937, DOI: 10.1093/annonc/mdl388.
- Arcaini L, Burcheri S, Rossi A, Pascutto C, Passamonti F, Brusamolino E, Paulli M, Orlandi E, Buelli M, Viero P, Lucioni M, Montanari F, Merli M, Cortelazzo S, Lazzarino M. Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern Italy. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2007, 13: 182-6. PMID: 17200353, DOI: 10.1158/1078-0432.CCR-06-0703.
- Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F, Lucioni M, Motta T, Canzonieri V, Montanari M, Bonoldi E, Gallamini A, Uziel L, Crugnola M, Ramponi A, Montanari F, Pascutto C, Morra E, Lazzarino M. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. British Journal Of Haematology 2007, 136: 301-4. PMID: 17233821, DOI: 10.1111/j.1365-2141.2006.06437.x.
- Arcaini L, Colombo N, Bernasconi P, Calatroni S, Passamonti F, Orlandi E, Bonfichi M, Burcheri S, Porta MD, Rumi E, Montanari F, Algarotti A, Pascutto C, Lazzarino M. Role of the molecular staging and response in the management of follicular lymphoma patients. Leukemia & Lymphoma 2006, 47: 1018-22. PMID: 16840191, DOI: 10.1080/10428190500467834.
- Arcaini L, Colombo N, Passamonti F, Burcheri S, Orlandi E, Brusamolino E, Della Porta M, Rumi E, Montanari F, Pascutto C, Paulli M, Lazzarino M. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment. Leukemia Research 2006, 30: 277-82. PMID: 16112730, DOI: 10.1016/j.leukres.2005.07.006.
- Arcaini L, Burcheri S, Rossi A, Passamonti F, Paulli M, Boveri E, Brusamolino E, Orlandi E, Molteni A, Pulsoni A, Cox MC, Orsucci L, Fabbri A, Frezzato M, Voso MT, Zaja F, Montanari F, Pascutto C, Morra E, Cortelazzo S, Lazzarino M. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. The Oncologist 2006, 11: 285-91. PMID: 16549813, DOI: 10.1634/theoncologist.11-3-285.
- Alessandrino EP, Bernasconi P, Colombo AA, Caldera D, Malcovati L, Troletti D, Vanelli L, Varettoni M, Montanari F, Lazzarino M. Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies. Bone Marrow Transplantation 2004, 34: 1039-45. PMID: 15516936, DOI: 10.1038/sj.bmt.1704717.
- A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.Arcaini L, Orlandi E, Alessandrino EP, Iacona I, Brusamolino E, Bonfichi M, Bernasconi P, Calatroni S, Tenore A, Montanari F, Troletti D, Pascutto C, Regazzi M, Lazzarino M. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma. Bone Marrow Transplantation 2004, 34: 175-9. PMID: 15170171, DOI: 10.1038/sj.bmt.1704551.
Departments and Programs
Locations
Smilow Cancer Hospital Care Center at Greenwich
77 Lafayette Place
Greenwich, CT 06830
- Smilow Cancer Hospital Care Center at Greenwich77 Lafayette PlaceGreenwich, CT 06830
Smilow Cancer Hospital Care Center at Greenwich
77 Lafayette Place
Greenwich, CT 06830
- Smilow Cancer Hospital Care Center at Greenwich77 Lafayette PlaceGreenwich, CT 06830